CGABL Fair Value & Analysis
Financials · US · Market cap $16.1B
What is CGABL really worth?
CGABL
CGABL · US
A solid business, but trading 51% above our fair value of $10.52.
Strengths
Risks
Fair value as of: Aug 13, 2026
From 11 valuation models · updated 22 days ago
Fair value updated Aug 13, 2026, revised from $10.72 to $10.52 (−1.9%) since Jul 9, 2026. Share price −1.2% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($14.15). The favourable scenario is already priced in.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range ($6.40 to $14.15) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range $12.35 – $19.84 · fair‑value band $6.40 – $14.15 · the $15.92 price screens above the $10.52 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
CGABL (CGABL) currently trades at $15.92, while our model-based Fair Value estimate is $10.52, implying the stock looks roughly 51.3% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Financials sector. Bull case: the Earnings-Based group reads highest at a median of $14.30 per share, and 3 of the 11 models we run sit above the $15.92 price. Bear case: the Asset-Based group reads lowest at $4.70, and 8 of the 11 models stay below the price. Evidence for this calculation is low.
It earns a return on equity of 68.7%. The balance sheet holds a net cash position of $2.0B. Fundamentals as of Aug 13, 2026
Our scenario range runs from $6.40 (bear case) to $14.15 (bull case); at $15.92, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 11% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financials peers we cover trades at −28% fair-value upside, at −34%, CGABL screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 11 models by family
Widest divergence: Earnings-Based ($14.30) versus Asset-Based ($4.70). Highest evidence: Growth DCF (72).
Notify me when CGABL reaches fair value
Put CGABL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 47
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CGABL reported revenue of $4.8B in FY2025 versus $8.8B in FY2021, a compound −14.1%/yr. Reported net income was $809M in FY2025, compounding −28.2%/yr from FY2021.
of which total revenue +1.8 % · buybacks/dilution −7.6 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
CGABL screens 51% overvalued. Compare with Blackstone Inc →
Peer Group
Asset Management · 697 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Asset Management median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Blackstone Inc BX | $142.39 | $52.88 | −63% |
| Investor AB INVEB | kr 417.20 | kr 824.66 | +98% |
| Brookfield Corporation BN | C$55.74 | C$10.67 | −81% |
| KKR & Co KKR | $108.68 | $19.97 | −82% |
| State Street Corporation STT | $193.33 | $138.33 | −28% |
| Ameriprise Financial, Inc AMP | $559.32 | $515.24 | −8% |
| Ares Management Corporation ARES | $143.10 | $30.88 | −78% |
| Northern Trust Corporation NTRS | $186.79 | $122.02 | −35% |
| Raymond James Financial, Inc RJF | $181.10 | $142.42 | −21% |
| T. Rowe Price Group TROW | $111.24 | $126.63 | +14% |
Compare CGABL with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is CGABL overvalued or undervalued?
What is the fair value of CGABL?
What is the quality score of CGABL?
What is the net profit margin of CGABL?
Watch CGABL in the live analysis
One click puts CGABL on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.